Incompatibility of Bisoprolol Fumarate with Some Super-disintegrating Agents

Journal Title: Journal of Pharmaceutical Research International - Year 2015, Vol 5, Issue 2

Abstract

Aims: Bisoprolol fumarate, a selective β1adrenoreceptor blocker, is usually formulated as immediate release tablet dosage form. While developing the immediate release tablet formula in laboratory, the assay and dissolution results were found below acceptance limit in some formulation. The formulations differed only in disintegrating agents. Therefore a chemical interaction was suspected with some of the disintegrants with the drug used in the formulas. The aims of this study were to find out the interaction with the specific excipient. Study Design: Consequently, a pilot study of binary mixture of Bisoprolol-excipients (conventionally used in solid dosage form, e.g. binder, diluents, disintegrating agents, glidants, dissolution enhancer etc.) was carried out in laboratory using different analytical methods such as dissolution tester, UV, HPLC, DSC etc. Also formulated tablets were studied. Place: Study was carried in drug testing and analytical research laboratory in Center for Advanced Research in Sciences, University of Dhaka. Results: From the study, bisoprolol fumarate was found quite incompatible with ‘sodium starch glycolate’(SSG) and ‘croscarmellose sodium’(CCS) both of which are used as disintegrating agents in conventional solid dosage forms. But other disintegrating agents such as kollidon CL (KCL) has shown no interaction towards bisoprolol fumarate. Conclusion: Thus from this study we reached a valuable conclusion that bisoprolol fumarate is quite incompatible with two disintegrating agents namely sodium starch glycolate and croscarmellose sodium. With sodium starch glycolate, the drug was found to be degraded by around 19% whereas with croscarmellose sodium degradation was estimated around 13% in freshly prepared tablets. On the other hand, kollidon CL is compatible with this drug in its solid dosage formulation.

Authors and Affiliations

Abu Afzal Mohammad Shakar, Md. Jamal Hossain, Ruhul Kayesh, Asma Rahman, Md. Zakir Sultan

Keywords

Related Articles

Activity Guided Fractionation of Ethanol Extract of Meriandra bengalensis against Anopheles Mosquito Larvae

Aim: To prevent proliferation of mosquito borne diseases, to improve quality of life, mosquito control is essential. Research was aimed to find alternative eco-friendly and bio-degradable strategies in mosquito control a...

Human Drug Targets Identification in Breast Cancer by Computationally Based DNA Microarray Analysis

Aims: The availability of large cDNA datasets make it feasible to find new genetic variants. In this study, we focused to perform micro array differential analysis of breast cancer dataset to reveal genetic mutants of th...

Factors Predicting Erythropoietin Responsiveness among Maintenance Hemodialysis Patients: Prospective Longitudinal Study

Aim: To characterize the longitudinal hemoglobin (Hgb) variability in response to erythropoietin (Epo) and to identify the influence of clinical factors on Hgb level and Epo responsiveness in a sample of hemodialysis (HD...

Formulation and Evaluation of Oral Elementary Osmotic Pump Tablets of Sumatriptan Succinate

Aim: In the present study, Sumatriptan succinate was formulated as oral elementary osmotic pump with a zero-order drug release profile. Methodology: The effect of different formulation variables i.e. different types of...

Neonatal Effects after Selective Serotonin Reuptake Inhibitors and Benzodiazepines Administration during Pregnancy

Aims: To evaluate whether the co-administration of benzodiazepines (BDZ) and selective serotonin and serotonin/norepinephrine reuptake inhibitors (SSRI/SNRI) during pregnancy is associated with an increased risk of absti...

Download PDF file
  • EP ID EP344477
  • DOI 10.9734/BJPR/2015/13956
  • Views 139
  • Downloads 0

How To Cite

Abu Afzal Mohammad Shakar, Md. Jamal Hossain, Ruhul Kayesh, Asma Rahman, Md. Zakir Sultan (2015). Incompatibility of Bisoprolol Fumarate with Some Super-disintegrating Agents. Journal of Pharmaceutical Research International, 5(2), 137-145. https://europub.co.uk/articles/-A-344477